An Overview of Dengue Fever
Archives of Advances in Biosciences,
Vol. 15 No. 1 (2024),
24 January 2024
https://doi.org/10.22037/aab.v15i1.44108
Abstract
Dengue fever has been reported in 129 countries worldwide, including 100 countries in the Mediterranean region, South America, and Southeast Asia. It results in approximately 40,000 deaths each year, and there have been significant outbreaks of dengue fever in these areas in recent years. Approximately 50% of the global population is presently susceptible to acquiring the dengue virus, which is classified as an emerging and re-emerging ailment that is likely to impact several nations in the foreseeable future. Despite the significant harm inflicted upon human health and the economic conditions of countries in recent years, dengue continues to be classified as a neglected disease, without the requisite attention and concerted efforts by countries to effectively manage it. Any actions taken in this domain are inherently constrained. Consequently, due to the significance of dengue fever, this study aims to comprehensively examine this matter.
- Dengue Fever
- Emerging and Reemerging Diseases
- Viral hemorrhagic Fever
How to Cite
References
Whitehorn J, Farrar J (2010). Dengue. Br. Med. Bull., 95: 161–173. https://doi.org/10.1093/bmb/ldq019
Whitehorn J, Farrar J (2014). editors. Dengue: Transmission, Diagnosis & Surveillance. Future Medicine Limited. https://doi.org/10.2217/ebo.13.743.
Global Strategy For Dengue prevention and Control, 2010-2020. Vector Ecology and Management Unit Department of Control of Neglected Tropical Diseases World Health Organization May 2012.
Khalili M, Aflatoonian MR, Hemati M, Mostafavi E, Aflatoonian B. Dengue fever serology in febrile patients in Southeast Iran. Journal of Kerman University of Medical Sciences. 2019 Jan 1;26(1):90-4.
Gupta N, Srivastava S, Jain A, Chaturvedi UC. Dengue in India. Indian J Med Res. 2012;136(3):373–90.
WHO. Dengue and severe dengue. Fact Sheet [Internet]. World Health Organization. 2022 [cited 2022 Jul 1]. Available from: https:// www. who.int/ news- room/ fact- sheets/ detail/ dengue- and- severe- dengue.
Neyts J, Leyssen P, De Clercq E. Infections with faviviridae. Verh K Acad Voor Geneeskd Van Belg. 1999;61(6):661–97.
Chen R, Vasilakis N. Dengue—Quo tu et quo vadis? Viruses [Internet]. 2011;3(9):1562–608.
Noble CG, Chen YL, Dong H, Gu F, Lim SP, Schul W, Wang QY, Shi PY. Strategies for development of dengue virus inhibitors. Antiviral research. 2010 Mar 1;85(3):450-62.
Newton ND, Hardy JM, Modhiran N, Hugo LE, Amarilla AA, Bibby S, et al. The structure of an infectious immature favivirus redefnes viral architecture and maturation. Sci Adv [Internet]. 2021;7(20):eabe4507. https:// doi. org/ 10. 1126/ sciadv. abe45 07.
Pierson TC, Diamond MS. Degrees of maturity: the complex structure and biology of faviviruses. Curr Opin Virol. 2012;2(2):168–75.
Goncalvez AP, Escalante AA, Pujol FH, Ludert JE, Tovar D, Salas RA, et al. Diversity and evolution of the envelope gene of dengue virus type 1. Virology [Internet]. 2002;303(1):110–9.
Waman VP, Kolekar P, Ramtirthkar MR, Kale MM, Kulkarni-Kale U. Analysis of genotype diversity and evolution of Dengue virus serotype 2 using complete genomes. PeerJ. 2016;4: e2326.
Nedjadi T, El-Kafrawy S, Sohrab SS, Despres P, Damanhouri G, Azhar E. Tacklingdengue fever: current status and challenges. Virol J 2015;12:212.
World Health Organization. Guidelines for dengue surveillance and mosquito control. 2nd ed. Manila: WHO Regional Ofce for the Western Pacifc. 2003. https:// apps. who. int/ iris/ bitst ream/ handle/ 10665/ 206987/92906 10689_ eng. pdf? seque nce= 1& isAll owed=y. Accessed 28 0ct 2020.
Braks MAH, Honório NA, Lourenço-De-Oliveira R, Juliano SA, Lounibos LP.Convergent habitat segregation of Aedes aegypti and Aedes albopictus (Diptera:Culicidae) in southeastern Brazil and Florida. J Med Entomol 2003;40(6):785–94.
CDC (2010). Locally acquired dengue – Key West, Florida, 2009–2010. Morbidity and Mortality Weekly Report, 59:577–581.
Gubler DJ, Meltzer MI (1999). Impact of dengue/dengue hemorrhagic fever on the developing world. Advances in Virus Research, 53:35–70.
Azari-Hamidian S. Checklist of Iranian mosquitoes (Diptera: Culicidae). J Vector Ecol. 2007;32(2):235- 42.
Khoshdel-Nezamiha F, Vatandoost H, AzariHamidian S, Bavani MM, Dabiri F, Entezar-Mahdi R, et al. Fauna and larval habitats of mosquitoes (Diptera: Culicidae) of West Azerbaijan Province, northwestern Iran. Iran J Arthropod Borne Dis. 2014;8(2):163-73.
Choumet V, Despres P. Dengue and other flavivirus infections. Rev Sci Tech. 2015;34(2):473- 8, 67-72.
Mattingly P, Knight K (1956). The mosquito of Arabia. I. Bull. Brit. Mus. (Nat. Hist.) Entomol., 4(3): 89–141.
Fakeeh M, Zaki A (2001). Virologic and serologic surveillance for dengue fever in Jeddah, Saudi Arabia, 1994-1999. Am. J. Trop. Med. Hyg., 65: 764-767.
Al-Azab AM, Zaituon AA, Al-Ghamdi KM, Al-Galil FM. Surveillance of dengue fever vector Aedes aegypti in different areas in Jeddah city Saudi Arabia. Advances in Animal and Veterinary Sciences. 2022;10(2):348-53.
Gubler, D (2002). The global emergence/resurgence of arboviral diseases as public health problems. Arch. Med. Res., 33: 330-342.
Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998 Jul;11(3):480-96. doi: 10.1128/CMR.11.3.480. PMID: 9665979; PMCID: PMC88892.
Barrett AD, Stanberry LR (2009). Vaccines for biodefense and emerging and neglected diseases. San Diego: Academic. pp. ۲۸۷–۳۲۳.
Halstead SB (2008). Dengue (Tropical Medicine: Science and Practice). River Edge, N.J: Imperial College Press. pp. 1–10. ISBN 1-84816-228-6.
Rush AB (1789). "An account of the bilious remitting fever, as it appeared in Philadelphia in the summer and autumn of the year 1780". Medical enquiries and observations. Philadelphia: Prichard and Hall. pp. ۱۰۴–۱۱۷.
Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev. 1990 Oct;3(4):376-96. doi: 10.1128/CMR.3.4.376. PMID: 2224837; PMCID: PMC358169.
Gould EA, Solomon T (2008). "Pathogenic flaviviruses".The Lancet. 371 (9611):500-9.
Weekly Epidemiological Record, No 8, 24 February 2012.
Global Strategy For Dengue prevention and Control, 2010-2020. Vector Ecology and Management Unit Department of Control of Neglected Tropical Diseases World Health Organization May 2012.
La Ruche G et al (2010). First two autochthonous dengue virus infections in metropolitan France, September 2010, Eurosurveillance, 15, Issue 39, 30 September 2010.
CDC (2010). Locally acquired dengue – Key West, Florida, 2009–2010. Morbidity and Mortality Weekly Report, 59:577–581.
WHO Vietnam. Dengue in Viet Nam [Internet]. 2020 [cited 2020 Mar 20].Available from:https://www.who.int/vietnam/health-topics/dengue.
Cuong HQ, Hien NT, Duong TN, Phong TV, Cam NN, Farrar J, Nam VS, ThaiKT, Horby P. Quantifying the emergence of dengue in Hanoi, Vietnam:1998–2009. PLoS Negl Trop Dis. 2011;5(9):e1322.
Toan DTT, Hu W, Quang Thai P, Hoat LN, Wright P, Martens P. Hot spot detection and spatio-temporal dispersion of dengue fever in Hanoi.Vietnam Glob Health Action. 2013;6(1):18632.https://doi.org/10.3402/gha.v6i0.18632.
Fakeeh M, Zaki AM. Dengue in Jeddah, Saudi Arabia, 1994-2002. Dengue Bulletin;2003.
Sowilem MM, Kamal HA, Khater EI. Life table characteristics of Aedes aegypti(Diptera:Culicidae) from Saudi Arabia. Trop Biomed 2013;30(2):301–14.
Aziz AT, Al-Shami SA, Mahyoub JA, Hatabbi M, Ahmad AH, Rawi CSM. An update on the incidence of dengue gaining strength in Saudi Arabia and current control approaches for its vector mosquito.(Short report)(Report). Parasites Vectors 2014;7:258.
Kholood K. Altassan, et al., Dengue fever in Saudi Arabia: A review of environmental and population factors impacting emergence and spread Travel . Medicine and Infectious Disease, https://doi.org/10.1016/j.tmaid.2019.04.006.
Kraemer MU, Sinka ME, Duda KA, Mylne AQ, Shearer FM, Barker CM, et al. The global distribution of the arbovirus vectors Aedes aegyptiand Ae. albopictus. Elife. 2015;4:e08347. https:// doi. org/ 10. 7554/ eLife. 08347.
Kraemer MU, Sinka ME, Duda KA, Mylne A, Shearer FM, Brady OJ, et al. The global compendium of Aedes aegyptiand Ae. albopictusoccurrence. Sci Data. 2015;2:150035.
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504–7. https:// doi. org/ 10. 1038/ natur e12060.
Chew CH, Woon YL, Amin F, Adnan TH, Abdul Wahab AH, Ahmad ZE, et al. Rural-urban comparisons of dengue seroprevalence in Malaysia. BMC Public Health. 2016;16:824. https:// doi. org/ 10. 1186/s12889- 016- 3496-9.
World Health Organization (WHO). Global strategy for dengue prevention and control 2012-2020. 20 avenue Appia, 1211 Geneva27, Switzerland. 2012.https://apps.who.int/iris/handle/10665/75303.
Degife LH, Worku Y, Belay D, Bekele A, Hailemariam Z. Factors associated with dengue fever outbreak in Dire Dawa administration city, October 2015, Ethiopia—case control study. BMC Public Health [Internet]. 2019;19(1):650. https:// doi. org/ 10. 1186/ s12889- 019- 7015-7.
Gutu MA, Bekele A, Seid Y, Mohammed Y, Gemechu F, Woyessa AB, et al. Another dengue fever outbreak in Eastern Ethiopia-An emerging public health threat. PLoS Negl Trop Dis. 2021;15(1): e0008992
Ahmed YM, Salah AA. Epidemiology of dengue fever in Ethiopian Somali region: retrospective health facility based study. Cent Afr J Public Health. 2016;2(2):51–6.
WHO. WHO supports Ethiopia’s response to a dengue fever outbreak in Somali Region [Internet]. World Health Organization. 2021 [cited 2022 Sep 5].
Global Strategy For Dengue prevention and Control, 2010-2020. Vector Ecology and Management Unit Department of Control of Neglected Tropical Diseases World Health Organization May 2012.
Meltzer MI et al (1998). Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984–1994. American Journal of Tropical Medicine and Hygiene, 59:265–271.
Tahir U, Khan UH, Zubair MS, Bahar EM. Wolbachia pipientis: A potential candidate for combating and eradicating dengue epidemics in Pakistan. Asian Pac J Trop Med. 2015;8(12):989-98. 4.
Quam MB, Sessions O, Kamaraj US, Rocklov J, Wilder-Smith A. Dissecting Japan's Dengue Outbreak in 2014. Am J Trop Med Hyg. 2016;94(2):409-12
World Health Organization. Dengue and severe dengue. [updated July 2016; cited 13 Sep 2016]. Available from: http://www.who.int/mediacentre/factsheets/fs117/en/
Hashemi T. Incidence of dengue fever and risk of its transmission to the Afghan travelers to tropical regions: A discussion paper. Journal of Inventions in Biomedical and Pharmaceutical Sciences. 2020 Aug 12;5(3):27-30.
Heydari M, Metanat M, Rouzbeh-Far MA, Tabatabaei SM, Rakhshani M, Sepehri-Rad N, Keshtkar-Jahromi M. Dengue fever as an emerging infection in southeast Iran. The American Journal of Tropical Medicine and Hygiene. 2018 May;98(5):1469.
Azizi K, Soltani A, Hashemi S.A, Dorzaban H, RT-PCR assessment of mosquitoes of the genus Aedes for natural infection . with the arbovirus causing dengue fever across Hormozgan Province, Iran, during 2017. 2ndInternational Congress of Vector-Borne Diseases & Climate Change;4thNational Congress of Medical Medical Entomology.Shiraz University of Medical Sciences, Shiraz, IRAN; Nov. 13-15, 2019.
CHINIKAR S, SHAH-HOSSEINI N MORADI M, and et al. The role of travelers in the epidemiology of Dengue Fever in Iran. 9th Asia Pacific Travel Health Conference, 2-5 May 2012.
Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current understanding of the pathogenesis of dengue virus infection. Curr Microbiol. 2021;78(1):17–32.
Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7-16.
Sellahewa KH. Pathogenesis of dengue haemorrhagic fever and its impact on case management. ISRN Infect Dis [Internet]. 2013;2013:1–6
Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis [Internet]. 2006;19(5):429–36.
Martina BEE, Koraka P, Osterhaus ADME. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev [Internet]. 2009;22(4):564–81. https:// doi. org/ 10. 1128/ CMR. 00035- 09
Begum F, Das S, Mukherjee D, Mal S, Ray U. Insight into the tropism of dengue virus in humans. Viruses. 2019;11(12):E1136.
Nachman RL, Rafi S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med. 2008;359(12):1261–70
Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013;158(7):1445–59.
Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci [Internet]. 2010;67(16):2773–86. https:// doi. org/ 10. 1007/ s00018- 010- 0357-z.
WHO. Dengue guidelines for diagnosis, treatment, prevention and control: new edition [Internet]. World Health Organization. 2009 [cited 2022 Jun 21]. Available from: https:// apps. who. int/ iris/ handle/ 10665/4418.
Gubler, DJ (2011). Prevention and Control of Aedes aegypti-borne Disease: Lesson learned from Past Successes and Failures. AsPac. J. Mol. Biol. Biotechnol, 19(3): 111-114.
Gubler DJ, Meltzer MI (1999). Impact of dengue/dengue hemorrhagic fever on the developing world. Advances in Virus Research, 53:35–70.
da Silva NS, Undurraga EA, Verro AT, Nogueira ML. Comparison between the traditional (1997) and revised (2009) WHO classifcations of dengue disease: a retrospective study of 30 670 patients. Trop Med Int Health [Internet]. 2018;23(12):1282–93. https:// doi. org/ 10. 1111/ tmi. 13155.
Mathew A, Rothman AL. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev. 2008;225:300–13.
Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nature medicine. 2003 Jul 1;9(7):921-7
Shepard DS et al (2004). Cost-effectiveness of a Pediatric Dengue Vaccine. Vaccine, 22:1275–1280.
CDC. Dengue: Healthcare-providers: diagnosis. [Internet]. Centres for Disease Control and Prevention. 2019 [cited 2022 Jul 15]. Available from: https:// www. cdc. gov/ dengue/ healt hcare- provi ders/ index. Html.
de Iani FCM, Caetano ACB, Cocovich JCW, Amâncio FF, Pereira MA, Adelino TÉR, et al. Dengue diagnostics: serious inaccuracies are likely to occur if pre-analytical conditions are not strictly followed. Mem Inst Oswaldo Cruz. 2021;115:e200287.
WHO. Dengue guidelines for diagnosis, treatment, prevention and control: new edition [Internet]. World Health Organization. 2009 [cited 2022 Jun 21]. Available from: https:// apps. who. int/ iris/ handle/ 10665/44188.
WHO. Laboratory testing for Zika virus and dengue virus infections; Interim guidance [Internet]. World Health Organization. 2022. Available from: https:// www. who. int/ publi catio ns/i/ item/ WHO- ZIKV-DENV- LAB- 2022.1
Falconar AKI, de Plata E, Romero-Vivas CME. Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated. Clin Vaccine Immunol CVI. 2006;13(9):1044–51.
WHO. Dengue and severe dengue. Fact Sheet [Internet]. World Health Organization. 2022 [cited 2022 Jul 1]. Available from: https:// www. who.int/ news- room/ fact- sheets/ detail/ dengue- and- severe- dengue.
Changal KH, Raina AH, Raina A, Raina M, Bashir R, Latief M, et al. Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: an observational hospital based clinico-serological study from North India. BMC Infect Dis. 2016;16(1):715.
Gluber DJ. The global emergence / resurgence of arboviral diseases as public health problems. Arch Med Res. 2002:33:330-42.
Meltzer MI et al (1998). Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984–1994. American Journal of Tropical Medicine and Hygiene, 59:265–271.
Shepard DS et al (2004). Cost-effectiveness of a Pediatric Dengue Vaccine. Vaccine, 22:1275–1280.
La Ruche G et al (2010). First two autochthonous dengue virus infections in metropolitan France, September 2010, Eurosurveillance, 15, Issue 39, 30 September 2010.
LAM SK. Dengue Hemorrhagic Fever. Rev Med Microbial 1995;6:39-48
Gubler DJ, Meltzer MI (1999). Impact of dengue/dengue hemorrhagic fever on the developing world. Advances in Virus Research, 53:35–70.
Meltzer MI et al (1998). Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984–1994. American Journal of Tropical Medicine and Hygiene, 59:265–271.
Ranjit S, Kissoon N (2010). "Dengue hemorrhagic fever and shock syndromes". Pediatr. Crit. Care Med. ۱۲ (۱): ۹۰–۱۰۰. doi:10.1097/PCC.0b013e3181e911a7.
Hashemi T. Incidence of dengue fever and risk of its transmission to the Afghan travelers to tropical regions: A discussion paper. Journal of Inventions in Biomedical and Pharmaceutical Sciences. 2020 Aug 12;5(3):27-30.
World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control. Available at: http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf. Accessed June 13, 2012.
Ranjit S, Kissoon N (2010). "Dengue hemorrhagic fever and shock syndromes". Pediatr. Crit. Care Med. ۱۲ (۱): ۹۰–۱۰۰
Ministry of Health. National Guidelines on Management of Dengue Fever and Hemorrhagic Fever in adults and children. Colombo, Sri Lanka: Ministry of Health; 2011.
Ngo NT, Cao XT, Kneen R, et al. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis. 2001;32:204–213.
Rajapakse S, Rodrigo C, Rajapakse A. Treatment of dengue fever. Infection and drug resistance. 2012 Jul 23:103-12.
Thomas SJ, Endy TP. Critical issues in dengue vaccine development. Curr Opin Infect Dis. 2011;24:442–450
Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg. 1952;1:30–50.
Halstead SB. Epidemiological studies of Thai haemorrhagic fever. Bull World Health Organ. 1966;35:80–81.
Rothman AL. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr Top Microbiol Immunol. 2010;338:83–98.
Lin CC, Huang YH, Shu PY. Characteristic of dengue disease in Taiwan. Am J Trop Med Hyg. 2010;82:731–739.
Kliks SC, Nimmannitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988;38:411–419.
Raviprakash K, Defang G, Burgess T, Porter K. Advances in dengue vaccine development. Hum Vaccin. 2009;5:520–528.
Chen L, Ewing D, Subramanian H, et al. A heterologous DNA primeVenezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques. J Virol. 2007;81:11634–11639.
Raviprakash K, Apt D, Brinkman A, et al. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques. Virology. 2006;353:166–173.
Thomas SJ. The necessity and quandaries of dengue vaccine development. J Infect Dis. 2011;203:299–303.
Nikookar SH, Fazeli Dinan M, Zaim M, Enayati A. Prevention and Control Policies of Dengue Vectors (Aedes aegypti and Aedes albopictus) in Iran. Iranian Journal of Health Sciences. 2023 Aug 10;11(3):143-56.
Wu JY, Lun ZR, James AA, Chen XG. Dengue fever in mainland China. The American journal of tropical medicine and hygiene. 2010 Sep;83(3):664.
World Health Organization, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Global vector control response 2017–2030 [Internet]. Geneva: World Health Organization; 2017. 51 p. Available from: https:// apps. who. int/ iris/handle/ 10665/ 259205.
Parks W, Lloyd L. Planning social mobilization and communication for dengue fever prevention and control: a step-by-step guide. World Health Organization; 2004.
- Abstract Viewed: 51 times